Send me a link:

*Text messaging rates may apply.

 Dow Down0.16% Nasdaq Up0.40%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS
11.32 Jul 23, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 35,465   63,921   283,068  
Cost of Revenue -   -   -  
Gross Profit 35,465   63,921   283,068  
Operating Expenses
Research Development103,999  80,345  64,657  
Selling General and Administrative41,057  43,682  38,710  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (109,591) (60,106) 179,701  
Income from Continuing Operations
Total Other Income/Expenses Net1,183  1,458  746  
Earnings Before Interest And Taxes(108,408)(58,648)180,447  
Interest Expense -   -  91  
Income Before Tax(108,408)(58,648)180,356  
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(108,408)(58,648)180,356  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (108,408) (58,648) 180,356  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (108,408) (58,648) 180,356  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.